Yokoyama, H., Hirao, K., Yamaguchi, K., Oishi, M., Lee, G., Yagi, N., . . . Kashiwagi, A. (2014). Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33). Libertas Academica.
Styl cytowania ChicagoYokoyama, Hiroki, Koichi Hirao, Kohei Yamaguchi, Mariko Oishi, Gendai Lee, Noriharu Yagi, Hiroshi Takamura, i Atsunori Kashiwagi. Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea And/or One or Two Other Oral Antidiabetic Drugs (JDDM 33). Libertas Academica, 2014.
Styl cytowania MLAYokoyama, Hiroki, et al. Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea And/or One or Two Other Oral Antidiabetic Drugs (JDDM 33). Libertas Academica, 2014.